Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP703031.RAPePXHUXfvu_a6-BnnsXm23je3X1uoO48EORWeqz0qnU130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP703031.RAPePXHUXfvu_a6-BnnsXm23je3X1uoO48EORWeqz0qnU130_assertion type Assertion NP703031.RAPePXHUXfvu_a6-BnnsXm23je3X1uoO48EORWeqz0qnU130_head.
- NP703031.RAPePXHUXfvu_a6-BnnsXm23je3X1uoO48EORWeqz0qnU130_assertion description "[Reduced Brg1 expression was observed in 32 (53.3%) of the 60 evaluable IPMN lesions and occurred more frequently in high-grade IPMNs (13 of 17 showed loss; 76%) compared to intermediate-grade (15 of 29 showed loss; 52%) and low-grade IPMNs (4 of 14 showed loss; 28%) (P = .03).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP703031.RAPePXHUXfvu_a6-BnnsXm23je3X1uoO48EORWeqz0qnU130_provenance.
- NP703031.RAPePXHUXfvu_a6-BnnsXm23je3X1uoO48EORWeqz0qnU130_assertion evidence source_evidence_literature NP703031.RAPePXHUXfvu_a6-BnnsXm23je3X1uoO48EORWeqz0qnU130_provenance.
- NP703031.RAPePXHUXfvu_a6-BnnsXm23je3X1uoO48EORWeqz0qnU130_assertion SIO_000772 21940037 NP703031.RAPePXHUXfvu_a6-BnnsXm23je3X1uoO48EORWeqz0qnU130_provenance.
- NP703031.RAPePXHUXfvu_a6-BnnsXm23je3X1uoO48EORWeqz0qnU130_assertion wasDerivedFrom befree-20150227 NP703031.RAPePXHUXfvu_a6-BnnsXm23je3X1uoO48EORWeqz0qnU130_provenance.
- NP703031.RAPePXHUXfvu_a6-BnnsXm23je3X1uoO48EORWeqz0qnU130_assertion wasGeneratedBy ECO_0000203 NP703031.RAPePXHUXfvu_a6-BnnsXm23je3X1uoO48EORWeqz0qnU130_provenance.